Phase I Dose Escalation Study for Neoadjuvant Radiosurgery

Phase I Dose Escalation Study for Neoadjuvant Radiosurgery

Cleveland Clinic

1 month
9 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:

Dr. Erin Murphy, MD of Cleveland Clinic explains the phase I dose escalation study for neoadjuvant radiosurgery for large brain metastases.

_____

Preoperative (neoadjuvant) stereotactic radiosurgery (SRS) with dose escalation followed by surgical resection for brain metastases > 2 cm yielded local control comparable to that with postoperative SRS or whole-brain radiation therapy (WBRT) — with the benefits of acceptable acute toxicity and a low incidence of leptomeningeal disease.

These preliminary findings from a Cleveland Clinic prospective phase 1/2 clinical trial were presented Sept. 15 at the 2019 annual meeting of the American Society for Radiation Oncology (ASTRO).

“So far we have seen excellent results with radiation doses higher than the current SRS standards,” says lead investigator Erin Murphy, MD, a radiation oncologist in Cleveland Clinic’s Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center. “If findings continue to be positive, we anticipate that new standards can be adopted to safely save more patients from recurring disease.”

Read the rest here: https://consultqd.clevelandclinic.org/high-dose-neoadjuvant-radiosurgery-for-brain-metastases-appears-safe-effective-in-early-results-from-phase-1-2-study/

Up Next Autoplay
When Can This Be Used In Clinical Practice?
When Can This Be Used In Clinical Practice?
Category: Other
1 Views
Baylor College of Medicine 1 day
New Testing for Thyroid Cancer
New Testing for Thyroid Cancer
Category: Other
2 Views
Baylor College of Medicine 1 day
Lower Costs for Patients in Metastatic Breast Cancer
Lower Costs for Patients in Metastatic Breast Cancer
Category: Breast Cancer
9 Views
ONeal Comprehensive Cancer Center 3 days
New Technology to Streamline Drug Discovery
New Technology to Streamline Drug Discovery
Category: Other
4 Views
Cancer-News 4 days
Using Technology to Better Understand What Goes Wrong in Cancer
Using Technology to Better Understand What Goes Wrong in Cancer
Category: Breast Cancer
10 Views
Cancer-News 4 days
How Does This Affect Clinicians Today?
How Does This Affect Clinicians Today?
Category: Breast Cancer
4 Views
Cancer-News 4 days
Measuring Chromatin Accessibility: How Reliable is This Data?
Measuring Chromatin Accessibility: How Reliable is This Data?
Category: Breast Cancer
4 Views
Cancer-News 4 days
Dual-function Virus Designed For Killing Tumor Cells and Helping Immune Cells
Dual-function Virus Designed For Killing Tumor Cells and Helping Immune Cells
Category: Melanoma and Skin Cancer
9 Views
Cancer-News 4 days
Mapping the usual breast development to recognize cancer better
Mapping the usual breast development to recognize cancer better
Category: Breast Cancer
9 Views
Cancer-News 4 days
Metformin: How Does This Affect Treatment?
Metformin: How Does This Affect Treatment?
Category: Ovarian Cancer
10 Views
Cancer-News 4 days